NCT05411133 2026-03-19
Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients
Arbele Limited
Phase 1 Completed
Arbele Limited
Janssen Research & Development, LLC
National Institutes of Health Clinical Center (CC)
Boehringer Ingelheim
Replimune Inc.
Pilatus Biosciences Inc